Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?

被引：0
|
作者：
André Hennigs
Melitta Köpke
Manuel Feißt
Fabian Riedel
Mahdi Rezai
Ulrike Nitz
Mareike Moderow
Michael Golatta
Christof Sohn
Andreas Schneeweiss
Jörg Heil
机构：
[1] University of Heidelberg,Department of Gynecology and Obstetrics
[2] University of Heidelberg,Institute of Medical Biometry and Informatics
[3] Luisen Hospital,European Breast Center
[4] Evangelical Hospital Johanniter Bethesda,National Center for Tumor Diseases
[5] Breast Center Niederrhein,undefined
[6] West German Breast Center Ltd,undefined
[7] University of Heidelberg,undefined
来源：
Breast Cancer Research and Treatment | 2019年 / 173卷
关键词：
Breast cancer; Axillary lymph node dissection; Mastectomy; ACOSOG Z0011; Time-tend analysis; Sentinel lymph node dissection; Tumour-involved sentinel lymph node;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：429 / 438
页数：9
相关论文
共 50 条
  • [1] Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?
    Hennigs, Andre
    Koepke, Melitta
    Feisst, Manuel
    Riedel, Fabian
    Rezai, Mahdi
    Nitz, Ulrike
    Moderow, Mareike
    Golatta, Michael
    Sohn, Christof
    Schneeweiss, Andreas
    Heil, Joerg
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 173 (02) : 429 - 438
  • [2] Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer
    Noguchi, M.
    EJSO, 2008, 34 (02): : 129 - 134
  • [3] Sentinel lymph node biopsy as an alternative to routine axillary lymph node dissection in breast cancer patients
    Noguchi, M
    JOURNAL OF SURGICAL ONCOLOGY, 2001, 76 (02) : 144 - 156
  • [4] Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial
    Jana de Boniface
    Jan Frisell
    Yvette Andersson
    Leif Bergkvist
    Johan Ahlgren
    Lisa Rydén
    Roger Olofsson Bagge
    Malin Sund
    Hemming Johansson
    Dan Lundstedt
    BMC Cancer, 17
  • [5] Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial
    de Boniface, Jana
    Frisell, Jan
    Andersson, Yvette
    Bergkvist, Leif
    Ahlgren, Johan
    Ryden, Lisa
    Bagge, Roger Olofsson
    Sund, Malin
    Johansson, Hemming
    Lundstedt, Dan
    BMC CANCER, 2017, 17
  • [6] Axillary Irradiation as an Imperative Alternative to Axillary Dissection in Clinically Lymph Node-Negative but Sentinel Node-Positive Breast Cancer Patients?
    Nitsche, Mirko
    Hermann, Robert
    BREAST CARE, 2011, 6 (05) : 353 - 358
  • [7] Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level
    Qianqian Yuan
    Jinxuan Hou
    Yukun He
    Yiqian Liao
    Lewei Zheng
    Gaosong Wu
    BMC Cancer, 21
  • [8] The Role for Sentinel Lymph Node Dissection after Neoadjuvant Chemotherapy in Patients who Present with Node-Positive Breast Cancer
    Rosalinda Alvarado
    Min Yi
    Huong Le-Petross
    Michael Gilcrease
    Elizabeth A. Mittendorf
    Isabelle Bedrosian
    Rosa F. Hwang
    Abigail S. Caudle
    Gildy V. Babiera
    Jeri S. Akins
    Henry M. Kuerer
    Kelly K. Hunt
    Annals of Surgical Oncology, 2012, 19 : 3177 - 3184
  • [9] Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level
    Yuan, Qianqian
    Hou, Jinxuan
    He, Yukun
    Liao, Yiqian
    Zheng, Lewei
    Wu, Gaosong
    BMC CANCER, 2021, 21 (01)
  • [10] Sentinel node biopsy to avoid axillary lymph node dissection in breast cancer
    Motomura K.
    Komoike Y.
    Nagumo S.
    Kasugai T.
    Hasegawa Y.
    Inaji H.
    Noguchi S.
    Koyama H.
    Breast Cancer, 2002, 9 (4) : 337 - 343
12345